Michael W. Kuzniewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael W. Kuzniewicz has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Thomas B. Newman
3 shared publications- Eduard Eric Vasilevskis
Section of Hospital Medicine, Division of General Internal Medicine and Public Health Vanderbilt University, Nashville, TN, USA
2 shared publications Gabriel J. Escobar
Division of Research, Perinatal Research Unit, Kaiser Permanente Medical Care Program, Oakland, California
2 shared publications- Andrea C. Wickremasinghe
Department of Pediatrics, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA
1 shared publication - Brian A. Cason1 shared publication
David Draper
Department of Applied Mathematics and Statistics, Baskin School of Engineering, University of California, Santa Cruz, USA
1 shared publication
Latest Publications
- Open Access
- 31 October 2013
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 178 (12) , 1698-1701
Invited Commentary: Does Neonatal Hyperbilirubinemia Cause Asthma?
In an analysis of data from the US Collaborative Perinatal Project, Huang et al. (Am J Epidemiol. 2013;178(12):1691–1697) report an association between neonatal total serum bilirubin levels and childhood asthma. To consider the implications of this finding, we need to evaluate whether the association is causal. The results do not appear to be due to chance or any obvious biases. It is likely that the observed association is the result of a common cause of both hyperbilirubinemia and asthma (confounding). Polymorphisms in the glutathione S-transferase gene are a potential genetic confounder. The glutathione S-transferase M1-null phenotype has been linked to both neonatal hyperbilirubinemia and asthma in several studies. Before making any changes in practice aimed at lowering peak bilirubin levels to reduce asthma risk, it is vital to determine not only whether the association between higher bilirubin levels and asthma risk is causal, but also whether interventions to reduce peak bilirubin levels (or their duration) are associated with decreased risk of asthma (without evidence of other adverse effects). The study by Huang et al. should encourage further investigation of these questions.
- 31 October 2013
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 178 (12) , 1698-1701
Open AccessInvited Commentary: Does Neonatal Hyperbilirubinemia Cause Asthma?
In an analysis of data from the US Collaborative Perinatal Project, Huang et al. (Am J Epidemiol. 2013;178(12):1691–1697) report an association between neonatal total serum bilirubin levels and childhood asthma. To consider the implications of this finding, we need to evaluate whether the association is causal. The results do not appear to be due to chance or any obvious biases. It is likely that the observed association is the result of a common cause of both hyperbilirubinemia and asthma (confounding). Polymorphisms in the glutathione S-transferase gene are a potential genetic confounder. The glutathione S-transferase M1-null phenotype has been linked to both neonatal hyperbilirubinemia and asthma in several studies. Before making any changes in practice aimed at lowering peak bilirubin levels to reduce asthma risk, it is vital to determine not only whether the association between higher bilirubin levels and asthma risk is causal, but also whether interventions to reduce peak bilirubin levels (or their duration) are associated with decreased risk of asthma (without evidence of other adverse effects). The study by Huang et al. should encourage further investigation of these questions.
- 1 March 2011
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 39 (3) , 429-435
The effect of race and ethnicity on outcomes among patients in the intensive care unit: A comprehensive study involving socioeconomic status and resuscitation preferences*
Objective: We sought to determine whether race or ethnicity is independently associated with mortality or intensive care unit length of stay among critically ill patients after accounting for patients' clinical and demographic characteristics including socioeconomic status and resuscitation preferences. Design: Historical cohort study of patients hospitalized in intensive care units. Setting: Adult intensive care units in 35 California hospitals during the years 2001–2004. Patients: A total of 9,518 intensive care unit patients (6,334 white, 655 black, 1,917 Hispanic, and 612 Asian/Pacific Islander patients). Measurements and Main Results: The primary outcome was risk-adjusted mortality and a secondary outcome was risk-adjusted intensive care unit length of stay. Crude hospital mortality was 15.9% among the entire cohort. Asian patients had the highest crude hospital mortality at 18.6% and black patients had the lowest at 15.0%. After adjusting for age and gender, Hispanic and Asian patients had a higher risk of death compared to white patients, but these differences were not significant after additional adjustment for severity of illness. Black patients had more acute physiologic derangements at intensive care unit admission and longer unadjusted intensive care unit lengths of stay. Intensive care unit length of stay was not significantly different among racial/ethnic groups after adjustment for demographic, clinical, and socioeconomic factors and do-not-resuscitate status. In an analysis restricted only to those who died, decedent black patients averaged 1.1 additional days in the intensive care unit (95% confidence interval, 0.26–2.6) compared to white patients who died, although this was not statistically significant. Conclusions: Hospital mortality and intensive care unit length of stay did not differ by race or ethnicity among this diverse cohort of critically ill patients after adjustment for severity of illness, resuscitation status, socioeconomic status, insurance status, and admission type. Black patients had more acute physiologic derangements at intensive care unit admission and were less likely to have a do-not-resuscitate order. These results suggest that among intensive care unit patients, there are no racial or ethnic differences in mortality within individual hospitals. If disparities in intensive care unit care exist, they may be explained by differences in the quality of care provided by hospitals that serve high proportions of minority patients.
- 1 March 2011
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 39 (3) , 429-435
The effect of race and ethnicity on outcomes among patients in the intensive care unit: A comprehensive study involving socioeconomic status and resuscitation preferences*
Objective: We sought to determine whether race or ethnicity is independently associated with mortality or intensive care unit length of stay among critically ill patients after accounting for patients' clinical and demographic characteristics including socioeconomic status and resuscitation preferences. Design: Historical cohort study of patients hospitalized in intensive care units. Setting: Adult intensive care units in 35 California hospitals during the years 2001–2004. Patients: A total of 9,518 intensive care unit patients (6,334 white, 655 black, 1,917 Hispanic, and 612 Asian/Pacific Islander patients). Measurements and Main Results: The primary outcome was risk-adjusted mortality and a secondary outcome was risk-adjusted intensive care unit length of stay. Crude hospital mortality was 15.9% among the entire cohort. Asian patients had the highest crude hospital mortality at 18.6% and black patients had the lowest at 15.0%. After adjusting for age and gender, Hispanic and Asian patients had a higher risk of death compared to white patients, but these differences were not significant after additional adjustment for severity of illness. Black patients had more acute physiologic derangements at intensive care unit admission and longer unadjusted intensive care unit lengths of stay. Intensive care unit length of stay was not significantly different among racial/ethnic groups after adjustment for demographic, clinical, and socioeconomic factors and do-not-resuscitate status. In an analysis restricted only to those who died, decedent black patients averaged 1.1 additional days in the intensive care unit (95% confidence interval, 0.26–2.6) compared to white patients who died, although this was not statistically significant. Conclusions: Hospital mortality and intensive care unit length of stay did not differ by race or ethnicity among this diverse cohort of critically ill patients after adjustment for severity of illness, resuscitation status, socioeconomic status, insurance status, and admission type. Black patients had more acute physiologic derangements at intensive care unit admission and were less likely to have a do-not-resuscitate order. These results suggest that among intensive care unit patients, there are no racial or ethnic differences in mortality within individual hospitals. If disparities in intensive care unit care exist, they may be explained by differences in the quality of care provided by hospitals that serve high proportions of minority patients.
- 1 October 2009
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 124 (4) , 1031-1039
Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use
OBJECTIVE: The goal was to assess the impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. METHODS: In this retrospective cohort study of 358086 infants of ≥35 weeks and ≥2000 g born between January 1, 1995, and June 30, 2007, we obtained demographic data, bilirubin levels, and codes for inpatient phototherapy from existing databases. We compared the incidence of high total serum bilirubin (TSB) levels and phototherapy before and after implementation of universal screening and examined risk factors for high TSB levels. RESULTS: A total of 38182 infants (10.6%) were born at facilities that had implemented universal bilirubin screening. Compared with infants born at facilities that were not screening, these infants had a 62% lower incidence of TSB levels exceeding the American Academy of Pediatrics exchange guideline (0.17% vs 0.45%; P < .001), received twice the inpatient phototherapy (9.1% vs 4.2%; P < .001), and had slightly longer birth hospitalization lengths of stay (50.9 vs 48.7 hours; P < .001). Of those receiving phototherapy, 56% after initiation of universal screening had TSB levels at which phototherapy was recommended by the guideline, compared with 70% before screening. The adjusted odds ratio for developing TSB levels exceeding the guideline value was 0.28 (95% confidence interval: 0.20–0.40) for those born at a facility using TSB screening and 0.28 (95% confidence interval: 0.19–0.42) for those born at a facility using transcutaneous bilirubin screening. CONCLUSIONS: Universal bilirubin screening was associated with a significantly lower incidence of severe hyperbilirubinemia but also with increased phototherapy use.
- 1 October 2009
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 124 (4) , 1031-1039
Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use
OBJECTIVE: The goal was to assess the impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. METHODS: In this retrospective cohort study of 358086 infants of ≥35 weeks and ≥2000 g born between January 1, 1995, and June 30, 2007, we obtained demographic data, bilirubin levels, and codes for inpatient phototherapy from existing databases. We compared the incidence of high total serum bilirubin (TSB) levels and phototherapy before and after implementation of universal screening and examined risk factors for high TSB levels. RESULTS: A total of 38182 infants (10.6%) were born at facilities that had implemented universal bilirubin screening. Compared with infants born at facilities that were not screening, these infants had a 62% lower incidence of TSB levels exceeding the American Academy of Pediatrics exchange guideline (0.17% vs 0.45%; P < .001), received twice the inpatient phototherapy (9.1% vs 4.2%; P < .001), and had slightly longer birth hospitalization lengths of stay (50.9 vs 48.7 hours; P < .001). Of those receiving phototherapy, 56% after initiation of universal screening had TSB levels at which phototherapy was recommended by the guideline, compared with 70% before screening. The adjusted odds ratio for developing TSB levels exceeding the guideline value was 0.28 (95% confidence interval: 0.20–0.40) for those born at a facility using TSB screening and 0.28 (95% confidence interval: 0.19–0.42) for those born at a facility using transcutaneous bilirubin screening. CONCLUSIONS: Universal bilirubin screening was associated with a significantly lower incidence of severe hyperbilirubinemia but also with increased phototherapy use.
- 1 March 2009
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 123 (3) , 1045-1050
Interaction of Hemolysis and Hyperbilirubinemia on Neurodevelopmental Outcomes in the Collaborative Perinatal Project
OBJECTIVE. Our objective was to reanalyze data from the Collaborative Perinatal Project to investigate whether bilirubin is more neurotoxic in newborns with a positive direct antiglobulin test.PATIENTS AND METHODS. The Collaborative Perinatal Project enrolled 54795 newborns at 12 centers in the United States between 1959 and 1966. We restricted our analysis to those with a birth weight of ≥2000 g and gestational age of ≥36 weeks who had follow-up at 7 to 8 years of age (n = 32808 for IQ testing; n = 33278 for neurologic examination, and n = 16354 for hearing testing). We examined the association between maximum total serum bilirubin levels and these 3 neurodevelopmental outcomes by using multiple linear and logistic regression models. We included interaction terms for the effect of bilirubin category and direct antiglobulin test result on the neurodevelopmental outcome.RESULTS. Overall, maximum total serum bilirubin level was not a significant predictor of IQ scores. However, there was a statistically significant interaction between a positive direct antiglobulin test and a maximum total serum bilirubin level of ≥25 mg/dL on IQ scores (eg, full-scale IQ: −6.7 points). No similar direct antiglobulin test interaction was seen for those with those with a total serum bilirubin of 20 to 24.9 mg/dL (eg, full-scale IQ: −1.7 points). We found no evidence of an interaction between a positive direct antiglobulin test and total serum bilirubin levels on the risk of an abnormal or suspicious neurologic examination or sensorineural hearing loss.CONCLUSIONS. In the Collaborative Perinatal Project, evidence of increased bilirubin toxicity in those with a positive direct antiglobulin test result was confined to an adverse association with IQ in those with total serum bilirubin of ≥25 mg/dL.
- 1 March 2009
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 123 (3) , 1045-1050
Interaction of Hemolysis and Hyperbilirubinemia on Neurodevelopmental Outcomes in the Collaborative Perinatal Project
OBJECTIVE. Our objective was to reanalyze data from the Collaborative Perinatal Project to investigate whether bilirubin is more neurotoxic in newborns with a positive direct antiglobulin test.PATIENTS AND METHODS. The Collaborative Perinatal Project enrolled 54795 newborns at 12 centers in the United States between 1959 and 1966. We restricted our analysis to those with a birth weight of ≥2000 g and gestational age of ≥36 weeks who had follow-up at 7 to 8 years of age (n = 32808 for IQ testing; n = 33278 for neurologic examination, and n = 16354 for hearing testing). We examined the association between maximum total serum bilirubin levels and these 3 neurodevelopmental outcomes by using multiple linear and logistic regression models. We included interaction terms for the effect of bilirubin category and direct antiglobulin test result on the neurodevelopmental outcome.RESULTS. Overall, maximum total serum bilirubin level was not a significant predictor of IQ scores. However, there was a statistically significant interaction between a positive direct antiglobulin test and a maximum total serum bilirubin level of ≥25 mg/dL on IQ scores (eg, full-scale IQ: −6.7 points). No similar direct antiglobulin test interaction was seen for those with those with a total serum bilirubin of 20 to 24.9 mg/dL (eg, full-scale IQ: −1.7 points). We found no evidence of an interaction between a positive direct antiglobulin test and total serum bilirubin levels on the risk of an abnormal or suspicious neurologic examination or sensorineural hearing loss.CONCLUSIONS. In the Collaborative Perinatal Project, evidence of increased bilirubin toxicity in those with a positive direct antiglobulin test result was confined to an adverse association with IQ in those with total serum bilirubin of ≥25 mg/dL.
- 19 June 2007
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (9) , 1602-1608
Incorporation of physiological trend and interaction effects in neonatal severity of illness scores: an experiment using a variant of the Richardson score
Objective To evaluate whether physiological trends and interaction terms could enhance predictive ability in a variant of the Richardson Score. Method We conducted a retrospective cohort study using data from 2,222 newborns of 34 weeks or more gestation with respiratory distress. The outcome variable was assisted ventilation longer 3 days or death. Using logistic regression and split validation we fit models for a variant of the Richardson score (gestational age, worst PaO2/FIO2 ratio, lowest MAP, and a single interaction variable relating the lowest pH and the highest PaCO2) as well as models incorporating variables for trends and additional interaction terms. We assessed discrimination using the c-statistic. Results The 24-h Richardson score had a c-statistic of 0.83. In the validation dataset, adding pH trend significantly increased the c-statistic to 0.87. Adding PaO2/FIO2 ratio trend increased the c-statistic to 0.86. Interactions with high significance were present in the data (e.g., adding all two-way interactions to our best trend model yielded a c-statistic of 0.92) but were unstably estimated with n = 2,222. Conclusions Incorporating trend and interaction terms in severity scores can enhance predictive ability. These modeling strategies have been underutilized in severity scoring, but in an era of increasing electronic availability of detailed clinical data the incorporation of trend and interaction effects in severity scoring will become both feasible and desirable.
- 19 June 2007
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (9) , 1602-1608
Incorporation of physiological trend and interaction effects in neonatal severity of illness scores: an experiment using a variant of the Richardson score
Objective To evaluate whether physiological trends and interaction terms could enhance predictive ability in a variant of the Richardson Score. Method We conducted a retrospective cohort study using data from 2,222 newborns of 34 weeks or more gestation with respiratory distress. The outcome variable was assisted ventilation longer 3 days or death. Using logistic regression and split validation we fit models for a variant of the Richardson score (gestational age, worst PaO2/FIO2 ratio, lowest MAP, and a single interaction variable relating the lowest pH and the highest PaCO2) as well as models incorporating variables for trends and additional interaction terms. We assessed discrimination using the c-statistic. Results The 24-h Richardson score had a c-statistic of 0.83. In the validation dataset, adding pH trend significantly increased the c-statistic to 0.87. Adding PaO2/FIO2 ratio trend increased the c-statistic to 0.86. Interactions with high significance were present in the data (e.g., adding all two-way interactions to our best trend model yielded a c-statistic of 0.92) but were unstably estimated with n = 2,222. Conclusions Incorporating trend and interaction terms in severity scores can enhance predictive ability. These modeling strategies have been underutilized in severity scoring, but in an era of increasing electronic availability of detailed clinical data the incorporation of trend and interaction effects in severity scoring will become both feasible and desirable.